167 related articles for article (PubMed ID: 18190591)
1. Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.
Jilani I; Wei C; Bekele BN; Zhang ZJ; Keating M; Wierda W; Ferrajoli A; Estrov Z; Kantarjian H; O'Brien SM; Giles FJ; Albitar M
Int J Lab Hematol; 2009 Feb; 31(1):97-105. PubMed ID: 18190591
[TBL] [Abstract][Full Text] [Related]
2. Soluble CD138 serum levels are not associated with other poor prognostic markers in patients with B-chronic lymphocytic leukaemia.
Alonci A; Allegra A; Bellomo G; D'Angelo A; Penna G; Cannavò A; Musolino C
Med Oncol; 2010 Dec; 27(4):1336-9. PubMed ID: 20013319
[TBL] [Abstract][Full Text] [Related]
3. Circulating sCD138 and some angiogenesis-involved cytokines help to anticipate the disease progression of early-stage B-cell chronic lymphocytic leukemia.
Wołowiec D; Dybko J; Wróbel T; Urbaniak-Kujda D; Jaźwiec B; Tomaszewska-Toporska B; Kapelko-Słowik K; Potoczek S; Kuliczkowski K
Mediators Inflamm; 2006; 2006(3):42394. PubMed ID: 16951490
[TBL] [Abstract][Full Text] [Related]
4. Syndecan-1 (sCD138) levels in chronic lymphocytic leukemia: clinical and hematological correlations.
Sharma M; Tyagi S; Tripathi P; Seth T
Blood Res; 2018 Sep; 53(3):205-209. PubMed ID: 30310786
[TBL] [Abstract][Full Text] [Related]
5. Biomarkers in HCV-related mixed cryoglobulinemia patients withnon-Hodgkin lymphoma.
Gulli F; Marino M; Napodano C; Pocino K; Pandolfi F; Gasbarrini A; Rapaccini GL; Basile U
Eur Rev Med Pharmacol Sci; 2020 Aug; 24(15):8067-8074. PubMed ID: 32767333
[TBL] [Abstract][Full Text] [Related]
6. Telomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.
Rampazzo E; Bonaldi L; Trentin L; Visco C; Keppel S; Giunco S; Frezzato F; Facco M; Novella E; Giaretta I; Del Bianco P; Semenzato G; De Rossi A
Haematologica; 2012 Jan; 97(1):56-63. PubMed ID: 21933855
[TBL] [Abstract][Full Text] [Related]
7. Bcl-6 mutation status provides clinically valuable information in early-stage B-cell chronic lymphocytic leukemia.
Sarsotti E; Marugan I; Benet I; Terol MJ; Sanchez-Izquierdo D; Tormo M; Rubio-Moscardo F; Martinez-Climent JA; García-Conde J
Leukemia; 2004 Apr; 18(4):743-6. PubMed ID: 14961033
[TBL] [Abstract][Full Text] [Related]
8. ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile.
Wiestner A; Rosenwald A; Barry TS; Wright G; Davis RE; Henrickson SE; Zhao H; Ibbotson RE; Orchard JA; Davis Z; Stetler-Stevenson M; Raffeld M; Arthur DC; Marti GE; Wilson WH; Hamblin TJ; Oscier DG; Staudt LM
Blood; 2003 Jun; 101(12):4944-51. PubMed ID: 12595313
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of prognostic factors in CLL: clinical stage, IGVH gene mutational status, and loss or mutation of the p53 gene are independent prognostic factors.
Oscier DG; Gardiner AC; Mould SJ; Glide S; Davis ZA; Ibbotson RE; Corcoran MM; Chapman RM; Thomas PW; Copplestone JA; Orchard JA; Hamblin TJ
Blood; 2002 Aug; 100(4):1177-84. PubMed ID: 12149195
[TBL] [Abstract][Full Text] [Related]
10. Study on expression of plasma sCD138 in patients with hemorrhagic fever with renal syndrome.
Li J; Du H; Bai XF; Wang XY; Zhang Y; Jiang H; Wang PZ
BMC Infect Dis; 2018 Mar; 18(1):100. PubMed ID: 29490629
[TBL] [Abstract][Full Text] [Related]
11. The predictive value of lipoprotein lipase for survival in chronic lymphocytic leukemia.
van't Veer MB; Brooijmans AM; Langerak AW; Verhaaf B; Goudswaard CS; Graveland WJ; van Lom K; Valk PJ
Haematologica; 2006 Jan; 91(1):56-63. PubMed ID: 16434371
[TBL] [Abstract][Full Text] [Related]
12. Distinctive IgVH gene segments usage and mutation status in Chinese patients with chronic lymphocytic leukemia.
Chen L; Zhang Y; Zheng W; Wu Y; Qiao C; Fan L; Xu W; Li J
Leuk Res; 2008 Oct; 32(10):1491-8. PubMed ID: 18359082
[TBL] [Abstract][Full Text] [Related]
13. ZAP-70 expression and prognosis in chronic lymphocytic leukaemia.
Orchard JA; Ibbotson RE; Davis Z; Wiestner A; Rosenwald A; Thomas PW; Hamblin TJ; Staudt LM; Oscier DG
Lancet; 2004 Jan; 363(9403):105-11. PubMed ID: 14726163
[TBL] [Abstract][Full Text] [Related]
14. Immunogenetics of chronic lymphocytic leukemia.
Patkar N; Rabade N; Kadam PA; Mishra F; Muranjan A; Tembhare P; Chaudhary S; Joshi S; Jain H; Dangi U; Bagal B; Khattry N; Menon H; Gujral S; Sengar M; Subramanian PG
Indian J Pathol Microbiol; 2017; 60(1):38-42. PubMed ID: 28195089
[TBL] [Abstract][Full Text] [Related]
15. Baff serum level predicts time to first treatment in early chronic lymphocytic leukemia.
Molica S; Digiesi G; Battaglia C; Cutrona G; Antenucci A; Molica M; Giannarelli D; Sperduti I; Gentile M; Morabito F; Ferrarini M
Eur J Haematol; 2010 Oct; 85(4):314-20. PubMed ID: 20546021
[TBL] [Abstract][Full Text] [Related]
16. A prognostic algorithm including a modified version of MD Anderson Cancer Center (MDACC) score predicts time to first treatment of patients with clinical monoclonal lymphocytosis (cMBL)/Rai stage 0 chronic lymphocytic leukemia (CLL).
Molica S; Giannarelli D; Levato L; Mirabelli R; Gentile M; Lentini M; Morabito F
Int J Hematol; 2014 Sep; 100(3):290-5. PubMed ID: 25064370
[TBL] [Abstract][Full Text] [Related]
17. Telomerase expression in B-cell chronic lymphocytic leukemia predicts survival and delineates subgroups of patients with the same igVH mutation status and different outcome.
Terrin L; Trentin L; Degan M; Corradini I; Bertorelle R; Carli P; Maschio N; Bo MD; Noventa F; Gattei V; Semenzato G; De Rossi A
Leukemia; 2007 May; 21(5):965-72. PubMed ID: 17344921
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-223 expression is uniformly down-regulated in B cell lymphoproliferative disorders and is associated with poor survival in patients with chronic lymphocytic leukemia.
Zhou K; Yi S; Yu Z; Li Z; Wang Y; Zou D; Qi J; Zhao Y; Qiu L
Leuk Lymphoma; 2012 Jun; 53(6):1155-61. PubMed ID: 22145958
[TBL] [Abstract][Full Text] [Related]
19. The significance of soluble CD138 in diagnosis of monoclonal gammopathies.
Maisnar V; Tousková M; Tichý M; Krejsek J; Chrobák L; Voglová J; Malý J
Neoplasma; 2006; 53(1):26-9. PubMed ID: 16416009
[TBL] [Abstract][Full Text] [Related]
20. Elevated serum level of circulating syndecan-1 (CD138) in active systemic lupus erythematosus.
Minowa K; Amano H; Nakano S; Ando S; Watanabe T; Nakiri Y; Amano E; Tokano Y; Morimoto S; Takasaki Y
Autoimmunity; 2011 Aug; 44(5):357-62. PubMed ID: 21320038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
